Observational Evaluation of the Peristomal Skin Condition in Ostomates (OSMOSE)

December 14, 2012 updated by: ConvaTec Inc.

Observational Evaluation of the Peristomal Skin Condition in Ostomates Using ConvaTec Moldable Technology™ Skin Barriers

The purpose of this study is to estimate the incidence and severity of peristomal skin lesions and evaluate the progression of the peristomal skin condition at 8-15 days following application of the barrier.

Study Overview

Status

Unknown

Conditions

Study Type

Observational

Enrollment (Anticipated)

2000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Arizona
      • Tucson, Arizona, United States, 85742
        • Independent Nurse Consultant
    • California
      • Concord, California, United States, 94520
        • John Muir Health Concord Campus
    • Connecticut
      • Plymoth, Connecticut, United States, 06782
        • Conn. Clinical Nursing Associate, LLC
    • Florida
      • Jacksonville, Florida, United States, 32207
        • Baptist Home Health
    • Indiana
      • Valparaiso, Indiana, United States, 46383
        • Porter Hospital
    • Massachusetts
      • Cambridge, Massachusetts, United States, 02140
        • Serena Group - Dr. Thomas Serena MD
    • Michigan
      • Clinton Township, Michigan, United States, 48038
        • Henry Ford Macomb Hospital
      • Detroit, Michigan, United States, 48201
        • Karmanos Cancer Center
    • Missouri
      • St. Louis, Missouri, United States, 63128
        • St. Anthony's Medical Center
    • Ohio
      • Columbus, Ohio, United States, 43222
        • ID Med Inc.
    • Rhode Island
      • Pawtucket, Rhode Island, United States, 02860
        • RI Colorectal Clinic, LLC
    • Texas
      • Baytown, Texas, United States, 77521
        • San Jacinto Methodist Hospital
    • Washington
      • Renton, Washington, United States, 98055
        • NW Pavillion Ostomy Clinic

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

colostomates, ileostomates, urostomates in acute care settings or community at large.

Description

Inclusion Criteria:

  • Subjects who are 18 years old and older.
  • Subjects who agree to participate in the evaluation and who have signed the informed consent form.
  • Subjects presenting with a stoma (ileostomy, colostomy or urostomy).
  • Subjects for whom a ConvaTec Moldable Technology™ Skin Barrier per package insert is used as the first long-term (within 7 days of ostomy surgery) system following surgery and have intact peristomal skin.

OR

  • Subjects presenting with peristomal skin lesions using a traditional barrier and for whom a decision to replace the traditional barrier with ConvaTec Moldable Technology™ Skin Barrier per package insert is made in the context of routine clinical care.

Exclusion Criteria:

  • Subjects who, according to the investigator, have cognitive problems that prevent them from answering a questionnaire or for whom the evaluation could be a problem.
  • Subjects who are in a simultaneous clinical evaluation.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
New moldable user
Subjects presenting with peristomal lesions with a traditional barrier and for whom a ConvaTec Moldable Technology™ Skin Barrier is used as a replacement.
New osomate
Subjects for whom a ConvaTec Moldable Technology™ Skin Barrier is used as the first long-term (within 7 days of ostomy surgery) system following surgery and have intact peristomal skin.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peristomal skin condition
Time Frame: At day 12
Change in peristomal skin condition from baseline as assessed with the SACS Instrument
At day 12

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Peristomal skin condition
Time Frame: at 1 month
Change in peristomal skin condition from baseline as assessed with the SACS instrument
at 1 month
Level of satisfaction
Time Frame: At 2 months
Subjects satisfaction as measured with a satisfaction survey
At 2 months
Accessory usage
Time Frame: Up to 2 months
Subjects use of additional products in stoma care.
Up to 2 months
Peristomal Skin Condition
Time Frame: At 2 months
Change in peristomal skin condition from baseline as assessed with the SACS instrument
At 2 months
Level of satisfaction
Time Frame: At 12 days
Subjects level of satisfaction as measured by a satisfaction survey
At 12 days
Level of satisfaction
Time Frame: At 1 month
Subjects level of satisfaction as measured with a satisfaction survey
At 1 month

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Investigators

  • Study Chair: Qing Li, Ph.D, MD, ConvaTec Inc.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

January 1, 2012

Primary Completion (Anticipated)

December 1, 2012

Study Completion (Anticipated)

December 1, 2012

Study Registration Dates

First Submitted

February 1, 2012

First Submitted That Met QC Criteria

February 2, 2012

First Posted (Estimate)

February 6, 2012

Study Record Updates

Last Update Posted (Estimate)

December 17, 2012

Last Update Submitted That Met QC Criteria

December 14, 2012

Last Verified

December 1, 2012

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • MA-0509-12-U359

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Ostomy

3
Subscribe